Roivant Sciences ROIV Balance Sheet Statement
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | ||
|---|---|---|---|---|---|---|
| $1.42B+1,444% | $91.94M-10.0% | $102.19M+7.8% | $94.79M+0.9% | $93.95M-5.2% | ||
| $2.87B-5.9% | $3.05B-3.1% | $3.15B-3.5% | $3.26B— | —— | ||
| —— | $2.61M+15.5% | $2.26M0.0% | $2.26M-4.2% | $2.36M-23.9% | ||
| $105.32M-18.9% | $129.91M+3.3% | $125.81M+11.7% | $112.6M-0.5% | $113.17M+96.3% | ||
| —— | —— | —— | —— | —— | ||
| $5.17B+10.9% | $4.66B+3.3% | $4.51B-2.3% | $4.62B-7.7% | $5B-6.8% | ||
| $11.99M-10.9% | $13.45M-47.6% | $25.67M+72.7% | $14.87M+23.3% | $12.06M-11.1% | ||
| $80.42M-3.8% | $83.56M-1.8% | $85.14M-2.2% | $87.08M-2.2% | $89.02M-2.1% | ||
| $40.92M+18.4% | $34.56M+24.2% | $27.83M-10.5% | $31.09M-5.4% | $32.86M-3.0% | ||
| $407.99M-6.0% | $433.91M+5.2% | $412.32M+45.3% | $283.81M-6.3% | $302.94M+4.4% | ||
| $5.71B+9.2% | $5.23B+3.2% | $5.06B+0.6% | $5.03B-7.4% | $5.44B-6.1% | ||
| $18M+35.4% | $13.29M-11.7% | $15.06M+30.4% | $11.55M-51.2% | $23.69M-0.1% | ||
| $583K-98.5% | $38.11M+44.5% | $26.37M-0.6% | $26.53M+2,172% | $1.17M-97.0% | ||
| —— | —— | —— | —— | $1.17M-61.5% | ||
| $11.15M+6.8% | $10.44M+15.9% | $9M-4.3% | $9.4M-4.5% | $9.84M+0.1% | ||
| $45.69M+537% | $7.17M-66.3% | $21.26M0.0% | $21.26M+5,011% | $416K-27.8% | ||
| —— | —— | —— | —— | —— | ||
| $281.24M+85.1% | $151.96M+13.5% | $133.86M+17.6% | $113.87M-23.8% | $149.41M+5.6% | ||
| $96.29M-2.2% | $98.5M+9.6% | $89.84M-0.5% | $90.29M0.0% | $90.33M-0.2% | ||
| —— | —— | —— | —— | —— | ||
| $70K-89.7% | $677K+298% | $170K-25.4% | $228K+936% | $22K-92.8% | ||
| $416.28M+65.8% | $251.14M-2.3% | $257.14M+18.7% | $216.7M-13.2% | $249.74M-2.6% | ||
| $0-100% | $7B0.0% | $7B0.0% | $7B— | $0-100% | ||
| $5.02B+1.6% | $4.94B+3.6% | $4.77B+2.8% | $4.64B+1.8% | $4.56B-3.4% | ||
| -$501.81M+27.8% | -$695M-62.0% | -$429.11M-36.0% | -$315.59M-372% | $116.06M-74.8% | ||
| $4.36M-78.9% | $20.61M+5.4% | $19.56M+14.1% | $17.14M+81.6% | $9.44M+17.1% | ||
| $765.04M+8.5% | $704.97M+59.1% | $443.13M-5.8% | $470.27M-5.9% | $499.59M+44.2% | ||
| $4.53B+6.0% | $4.27B-2.1% | $4.36B+0.4% | $4.35B-7.3% | $4.69B-9.7% | ||
| $5.71B+9.2% | $5.23B+3.2% | $5.06B+0.6% | $5.03B-7.4% | $5.44B-6.1% | ||
| —— | $1.49B+19.4% | $1.25B-0.1% | $1.25B-54.2% | $2.73B+36.2% | ||
| —— | $4.53B+3.3% | $4.39B-2.6% | $4.5B— | —— | ||
| —— | —— | —— | —— | —— | ||
| $2.87B-5.9% | $3.05B-3.1% | $3.15B-3.5% | $3.26B— | —— | ||
| $105.32M-18.9% | $129.91M+3.3% | $125.81M+11.7% | $112.6M-0.5% | $113.17M-48.0% | ||
| $40.92M+18.4% | $34.56M+24.2% | $27.83M-10.5% | $31.09M-5.4% | $32.86M-3.0% | ||
| $80.42M-3.8% | $83.56M-1.8% | $85.14M-2.2% | $87.08M-2.2% | $89.02M-2.1% | ||
| $80.42M-3.8% | $83.56M-1.8% | $85.14M-2.2% | $87.08M-2.2% | $89.02M-2.1% | ||
| $40.92M+18.4% | $34.56M+24.2% | $27.83M-10.5% | $31.09M-5.4% | $32.86M-3.0% | ||
| $80.42M-3.8% | $83.56M-1.8% | $85.14M-2.2% | $87.08M-2.2% | $89.02M-2.1% | ||
| $40.92M+18.4% | $34.56M+24.2% | $27.83M-10.5% | $31.09M-5.4% | $32.86M-3.0% | ||
| —— | $38.11M+44.5% | $26.37M-0.6% | $26.53M-50.8% | $53.93M+37.3% | ||
| $205.82M+74.4% | $117.99M+8.9% | $108.32M+22.1% | $88.73M-22.4% | $114.29M+9.6% | ||
| $205.82M+74.4% | $117.99M+8.9% | $108.32M+22.1% | $88.73M-22.4% | $114.29M+9.6% | ||
| —— | —— | —— | —— | $1.17M-61.5% | ||
| —— | $38.11M+44.5% | $26.37M-0.6% | $26.53M-50.8% | $53.93M+37.3% | ||
| $583K-94.3% | $10.24M+594% | $1.48M-64.7% | $4.19M+258% | $1.17M-67.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| —— | 709.7M+2.9% | 689.7M+1.1% | 682.2M-2.0% | 695.9M-3.3% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| —— | 0— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $55.72M-5.4% | $58.93M+18.3% | $49.8M+8.7% | $45.81M-14.3% | ||
| —— | $1.49B+19.4% | $1.25B-0.1% | $1.25B-54.2% | $2.73B+36.2% | ||
| —— | $00.0% | $00.0% | $00.0% | $00.0% | ||
| —— | $7B0.0% | $7B0.0% | $7B0.0% | $7B0.0% | ||
| —— | $709.69M+2.9% | $689.7M+1.1% | $682.23M-2.0% | $695.94M-3.3% | ||
| —— | $709.69M+2.9% | $689.7M+1.1% | $682.23M-2.0% | $695.94M-3.3% | ||
| —— | —— | —— | —— | —— | ||
| $407.99M-6.0% | $433.91M+5.2% | $412.32M+45.3% | $283.81M-6.3% | $302.94M+4.4% | ||
| —— | —— | —— | —— | —— | ||
| $0— | $0-100% | $33.27M+170% | $12.31M+23.3% | $9.98M-58.6% | ||
| —— | —— | —— | —— | —— | ||
| $765.04M+8.5% | $704.97M+59.1% | $443.13M-5.8% | $470.27M-5.9% | $499.59M+44.2% | ||
| —— | $1.39B+22.2% | $1.13B-0.8% | $1.14B— | —— | ||
| —— | $24.16M+5.0% | $23.02M+85.8% | $12.39M-14.8% | $14.55M+25.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $0— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Roivant Sciences's total assets?
- Roivant Sciences (ROIV) holds $5.7B in total assets, up 5.0% year over year.
- How much debt does Roivant Sciences have?
- Roivant Sciences carries $107.4M in total debt against $4.5B of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Roivant Sciences have?
- Roivant Sciences holds $1.4B in cash and equivalents.
- Can Roivant Sciences cover its short-term obligations?
- Its current ratio is 18.37 — current assets exceed current liabilities.
- Where does Roivant Sciences's balance sheet data come from?
- Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
